4.55

0.55% -0.025

After Hours: 4.89 0.34 +7.47%

Creative Medical Technology Holdings Inc (CELZ)

Overview News Price History Financials Discussions Forecast Stock Split

Creative Medical Technology Holdings Inc stock is currently priced at $4.55, with a 24-hour trading volume of 987. It has seen a -0.55% decreased in the last 24 hours and a -19.04% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $4.58 pivot point. If it approaches the $4.58 support level, significant changes may occur.

Previous Close:

$4.575

Open:

$4.55

24h Volume:

987

Market Cap:

$6.17M

Revenue:

$102.80K

Net Income/Loss:

$-5.29M

P/E Ratio:

-0.6083

EPS:

-7.48

Net Cash Flow:

$-8.13M

1W Performance:

+3.41%

1M Performance:

-19.04%

6M Performance:

+3.41%

1Y Performance:

+580.12%

1D Range:

$4.55

52W Range:

$0.4074

$10.28

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Name

Creative Medical Technology Holdings Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

480 399 2822

Address

211 East Osborn Road, Phoenix

Employee

Twitter

Next Earnings Date

2024-05-10

Latest SEC Filings

CELZ's Discussions on Twitter

Creative Medical Technology Holdings Inc Stock (CELZ) Latest News

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Creative Medical (CELZ) Up on Orphan Drug Tag for CELZ-101

Zacks Investment Research

Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?

Zacks Investment Research

Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data

Creative Medical Technology Holdings Inc (CELZ) Revenue 2024

CELZ reported a revenue (TTM) of $102.80 thousand for the quarter ending March 31, 2022.

Creative Medical Technology Holdings Inc (CELZ) Net Income 2024

CELZ net income (TTM) was -$5.29 million for the quarter ending December 31, 2023, a +47.88% increase year-over-year.

Creative Medical Technology Holdings Inc (CELZ) Cash Flow 2024

CELZ recorded a free cash flow (TTM) of -$8.13 million for the quarter ending December 31, 2023, a -4.24% decrease year-over-year.

Creative Medical Technology Holdings Inc (CELZ) Earnings per Share 2024

CELZ earnings per share (TTM) was -$3.71 for the quarter ending December 31, 2023, a +62.10% growth year-over-year.

Creative Medical Technology Holdings Inc Stock (CELZ) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Warbington Timothy	President & CEO	Jun 27 '23	Buy	4.44	800	3,551	12,009

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.